Posted on Feb 8, 2020

Government opens talks on cutting delays to provision of medical cannabis
The Pharmaceutical Journal7 FEB 2020By Corrinne Burns

Government bodies are discussing ways to mitigate delays in medical cannabis supply, which could involve allowing licensed wholesalers to hold reserve stock.

Jo Churchill portrait image

Source: Chris McAndrew / Wikimedia Commons

Jo Churchill, pharmacy minister, said the government was aware that some pharmacies had reported “challenges” in importing unlicensed cannabis-based medical products

The UK government is considering whether licensed wholesalers could hold reserve stocks of medical cannabis to reduce delays in patients receiving their medicines.

Jo Churchill, pharmacy minister, said in a parliamentary written answer published on 4 February 2020, that the government was “aware that some wholesalers and pharmacies have reported challenges in importing a range of unlicensed [cannabis-based medical products]”.

She said the Department of Health and Social care, the Medicines and Healthcare products Regulatory Agency (MHRA), the Home Office, NHS England and NHS Improvement were now discussing ways to mitigate such delays, which could include “exploring mechanisms to allow licensed wholesalers to hold a small reserve stock”.
Contact Us
Message sent. We'll get back to you soon.